5-alpha reductase inhibitors (5-ARI) and prostate cancer mortality among men with regular access to screening and health care.

39Background: The excess risk of high-grade prostate cancer in the Prostate Cancer Prevention Trial (PCPT) among men randomized to finasteride raised concerns that a chemoprevention benefit would b...